Sign in

You're signed outSign in or to get full access.

Shelly Chadwick

Vice President, Finance and Chief Financial Officer at MATERION
Executive

About Shelly Chadwick

Shelly M. Chadwick is Materion’s Vice President, Finance and Chief Financial Officer, serving in the role since at least November 2020 when a CFO sign‑on RSU grant was made; she continues to certify the company’s quarterly and Section 906 reports in 2025 . Company performance relevant to her incentive metrics: adjusted EBIT was $156.1M in 2023 (+~9% YoY), net income $95.7M, and adjusted EPS $5.64; value‑added sales grew ~1% in 2023 despite semiconductor headwinds . In 2024, MIP metrics landed below target—adjusted EBIT $131.0M, VAS growth −2.6%, SFCF $75.5M—driving payouts at 31.43% of target . Long‑term TSR PRSUs paid at the 78th percentile for the 2021–2023 cycle and ~58th percentile for 2022–2024, indicating above‑median shareholder return over multi‑year periods .

Fixed Compensation

Multi‑Year Summary Compensation

Metric202220232024
Salary ($)$444,193 $469,731 $495,270
Stock Awards ($)$564,545 $1,113,303 $976,862
Option Awards (SARs) ($)$127,048 $207,630 $211,932
Non‑Equity Incentive Plan (MIP) ($)$410,325 $216,249 $112,645
All Other Compensation ($)$20,214 $42,075 $60,902
Total ($)$1,566,325 $2,048,988 $1,857,611

Base Salary and Target Bonus

Metric20232024
Base Salary ($)$483,000 $512,000
YoY Salary Increase (%)5.00% 6.00%
Target Bonus (% of Salary)70% 70%
Actual MIP Paid ($)$216,249 $112,645

Performance Compensation

Annual MIP Structure and 2024 Outcomes

Metric (Weight)Threshold (25% funds)Target (100% funds)Maximum (200% funds)2024 Actual% of Target Earned
Adjusted EBIT (70%)$120.3M $160.4M $200.5M $131.0M 31.43%
Value‑Added Sales Growth (15%)—% 3.0% 8.0% −2.6% 0.00%
Simplified Free Cash Flow (15%)$82.9M $103.6M $124.3M $75.5M 0.00%
Total MIP Funding31.43%
  • 2024 MIP target mix for Chadwick: Adjusted EBIT 49% of salary, VAS 10.5%, SFCF 10.5% (total target 70%) .
  • Committee retains downward discretion for non‑financial factors; no adjustment was made in 2024 .

Long‑Term Incentive (LTI) Program and Grants

Vesting mechanics:

  • SARs: generally vest one‑third annually over three years; 7‑year term; settled in shares .
  • RSUs: generally vest one‑third annually over three years; time‑based; settled in shares .
  • PRSUs: three‑year performance period; RTSR vs peer percentiles and ROIC targets; 0–200% funding; settled in stock .

2024 equity grants (March 1, 2024):

Award TypeShares GrantedGrant Date Fair Value ($)
SARs4,200 $211,932
RTSR PRSUs (target)1,629 $314,283
ROIC PRSUs (target)1,629 $220,860
RSUs3,258 $441,720
Total$1,188,795

Special retention grants:

  • Aug 8, 2025: special award of 4,696 service‑based RSUs; intended to cliff vest and pay out in shares on the third anniversary, with alternative vesting on retirement, death, disability, certain involuntary terminations, or “double‑trigger” change‑in‑control per agreement .

Historical PRSU payouts:

Grant Year3‑Year PeriodCombined Payout %RTSR Percentile
20212021–2023149.0% 78.0%
20222022–202490.0% 57.8%

RTSR schedule (for 2024 grants): 25th percentile=50%, 50th=100%, 80th=200% .
ROIC schedule (2024 grants): 9.4%=50%, 11.8%=100%, ≥14.2%=200% .

Equity Ownership & Alignment

Beneficial Ownership

As of DateShares Beneficially OwnedPercent of ClassSARs Exercisable within 60 daysRSUs/PRSUs Vesting within 60 days
Jan 31, 202429,146 <1% 10,696 9,866
Jan 31, 202537,332 <1% 15,371 6,525

Outstanding Awards (12/29/2023 valuation for RSUs/PRSUs)

CategoryCountMarket/Payout Value ($)
Time‑based RSUs not vested14,975 $1,948,697
PRSUs unearned (at target)6,750 $878,378
SARs Exercisable5,494
SARs Unexercisable10,114
SARs Exercise Prices$68.82 (2018/2021 grants)
$80.85 (2019/2022 grants)
$113.28 (2023 grant)

Stock ownership guidelines:

  • Requirement: CFO must hold shares equal to 3× base salary; 5‑year compliance window; as of Dec 31, 2024 all covered NEOs met guidelines .
  • Anti‑hedging/pledging: prohibited for insiders (no margin/pledge; no hedging instruments) .

Employment Terms

Severance Agreements (non‑CIC and CIC):

ProvisionNon‑CIC Termination (Chadwick)Change‑in‑Control (CIC) + Qualifying Termination (Chadwick)
Cash severance multiple100% of highest annual salary + three‑year average cash incentive (target if <3 yrs) Two‑year basis using higher of target for year of termination or average of prior 3 years
Benefits continuationUp to 12 months medical & life Up to 24 months per CIC terms (two‑year period basis)
OutplacementUp to $20,000 $20,000
Annual MIP in CIC yearPro‑rata target MIP for CIC year (lump sum) Pro‑rata target value for CIC year
Equity vestingRSUs pro‑rated; PRSUs pro‑rated based on actual perf.; SARs pro‑rated vesting “Double‑trigger” acceleration per award terms upon CIC + qualifying termination
Tax gross‑upsNone (no 280G gross‑up; cut‑back only if beneficial) None (same)

Restrictive covenants and good reason:

  • Non‑compete/non‑solicit: generally two years post‑termination (one year for certain roles) .
  • “Good reason” definitions for equity agreements include material diminution in base pay or authority, relocation, or Company breach; cure periods apply .

Compensation Peer Group (benchmarking, RTSR comparator)

Advanced Energy Industries; Balchem; Carpenter Technology; CTS; Hexcel; Element Solutions; Fabrinet; Ingevity; Innospec; Kennametal; Knowles; Methode Electronics; Minerals Technologies; OSI Systems; Quaker Chemical; Rogers; Sensient Technologies; SMART Global Holdings; Standex International; Stepan; Viavi Solutions (2024 peer set; changes made to reflect Materion’s advanced materials focus) .

Targeting policy: NEO compensation initially targeted near median of peer and survey data; performance‑based equity comprises ~60% of target equity for CFO .

Say‑on‑Pay & Governance Signals

  • 2024 say‑on‑pay approval >94% of votes cast; Committee kept program consistent while committing to ongoing improvement .
  • Clawbacks: NYSE‑compliant compensation clawback policy (Oct 2, 2023) plus Supplemental Clawback Policy; awards also have detrimental‑conduct forfeiture/recoup provisions .
  • Related party transactions: none disclosed in 2024 .
  • Late Section 16 filings: one late Form 4 for Ms. Chadwick (and certain insiders) due to administrative error, covering RSU/PRSUs vesting and new grants .

Investment Implications

  • Pay‑for‑performance alignment: CFO’s cash incentive tied primarily to adjusted EBIT (70%) with secondary VAS and SFCF (15%/15%); 2024 payouts at 31.43% reflect disciplined governance when operational metrics undershoot, reducing near‑term cash compensation risk .
  • Retention and equity alignment: Robust multi‑year equity mix (PRSUs ~60% of CFO target equity opportunity) and 2025 special cliff RSU grant add retention hooks through 2028, while double‑trigger CIC terms mitigate turnover risk during strategic events .
  • Insider selling pressure: Significant unvested RSU/PRSU inventory and SARs (5,494 exercisable; 10,114 unexercisable as of 12/29/2023) suggest periodic vest/settle events; anti‑pledging and ownership‑holding requirements dampen immediate sell pressure and preserve alignment .
  • Execution track record: Above‑median TSR payouts (78th and ~58th percentiles on multi‑year cycles) indicate relative value creation, though 2024 operational headwinds (VAS decline and SFCF below target) warrant monitoring of margin recovery and cash generation into 2025–2026 PRSU cycles .
  • Governance risk mitigants: No excise tax gross‑ups, strong clawbacks, and explicit non‑compete/non‑solicit provisions reduce shareholder‑unfriendly features and bolster risk controls .
Citations: **[1104657_0001104657-24-000044_mtrn-20240325.htm:51]** **[1104657_0001104657-25-000191_mtrn-ex312_2025q310q.htm:0]** **[1104657_0001104657-25-000191_mtrn-ex32_2025q310q.htm:0]** **[1104657_0001104657-24-000044_mtrn-20240325.htm:24]** **[1104657_0001104657-24-000044_mtrn-20240325.htm:25]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:56]** **[1104657_0001104657-24-000044_mtrn-20240325.htm:38]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:59]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:68]** **[1104657_0001104657-24-000044_mtrn-20240325.htm:34]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:54]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:55]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:57]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:58]** **[1104657_0001104657-25-000157_mtrn-20250808.htm:1]** **[1104657_0001104657-24-000044_mtrn-20240325.htm:49]** **[1104657_0001104657-24-000044_mtrn-20240325.htm:20]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:20]** **[1104657_0001104657-24-000044_mtrn-20240325.htm:51]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:64]** **[1104657_0001104657-24-000044_mtrn-20240325.htm:59]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:60]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:81]** **[1104657_0001104657-25-000191_formof2025restrictedstocka.htm:2]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:54]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:49]** **[1104657_0001104657-24-000044_mtrn-20240325.htm:44]** **[1104657_0001104657-24-000044_mtrn-20240325.htm:45]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:41]** **[1104657_0001104657-25-000045_mtrn-20250327.htm:21]**